PRESS RELEASE published on 07/18/2024 at 19:37, 2 months 2 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Plc announces transaction in own shares, purchasing 158,976 ordinary shares at prices between 108.00p and 112.50p on the London Stock Exchange London Stock Exchange Share Buyback Own Shares Funding Circle Plc Transaction
BRIEF published on 07/17/2024 at 18:22, 2 months 3 days ago Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back Stock Exchange Transaction Numis Securities Funding Circle
BRIEF published on 07/17/2024 at 18:22, 2 months 3 days ago Funding Circle Plc : Transaction POS en actions propres Rachat D'actions Bourse Transaction Numis Securities Cercle De Financement
PRESS RELEASE published on 07/17/2024 at 18:17, 2 months 3 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces the purchase and cancellation of ordinary shares as part of its buy-back program on the London Stock Exchange. Details of the transactions disclosed London Stock Exchange Share Buyback Programme Own Shares Funding Circle Plc POS-Transaction
BRIEF published on 07/16/2024 at 18:17, 2 months 4 days ago Funding Circle Plc : Transaction POS en actions propres Rachat D'actions Actions Ordinaires Numis Securities Bourse De Londres Cercle De Financement
BRIEF published on 07/16/2024 at 18:17, 2 months 4 days ago Funding Circle Plc: POS-Transaction in Own Shares London Stock Exchange Ordinary Shares Share Buyback Numis Securities Funding Circle
PRESS RELEASE published on 07/16/2024 at 18:12, 2 months 4 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc purchased 290,396 of its ordinary shares for cancellation as part of its buy-back program. Share capital will consist of 345,743,513 shares post-cancellation Share Buy-back London Stock Exchange Ordinary Shares Funding Circle Plc Share Cancellation
BRIEF published on 07/15/2024 at 18:06, 2 months 5 days ago Funding Circle Plc : Transaction POS en actions propres Rachat D'actions Actions Ordinaires Numis Securities Bourse De Londres Cercle De Financement
BRIEF published on 07/15/2024 at 18:06, 2 months 5 days ago Funding Circle Plc: POS-Transaction in Own Shares Share Buy-back London Stock Exchange Ordinary Shares Numis Securities Funding Circle
PRESS RELEASE published on 07/15/2024 at 18:01, 2 months 5 days ago Funding Circle Plc: POS-Transaction in Own Shares Funding Circle Holdings plc announces the purchase and cancellation of 200,000 ordinary shares on the London Stock Exchange in a buy-back program, with detailed transaction information provided London Stock Exchange Ordinary Shares Cancellation Funding Circle Plc Buy-back
Published on 09/20/2024 at 23:40, 5 hours 10 minutes ago Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024
Published on 09/20/2024 at 23:30, 5 hours 20 minutes ago Final Bell Holdings International Ltd. Announces Sale of Final Bell Corp.
Published on 09/20/2024 at 23:00, 5 hours 50 minutes ago AI/ML Innovations Inc. Provides Second Status Update
Published on 09/20/2024 at 22:30, 6 hours 20 minutes ago Electric Metals Announces Changes to its Board of Directors
Published on 09/20/2024 at 22:15, 6 hours 35 minutes ago Torq Clarifies Finder’s Warrant Exercise Price of $0.10 Financing
Published on 09/20/2024 at 22:58, 5 hours 52 minutes ago Freelance.com: Mise à disposition du Document d’Enregistrement Universel 2023
Published on 09/20/2024 at 21:00, 7 hours 50 minutes ago Aurubis celebrates ribbon-cutting at the first multimetal recycling plant in the United States
Published on 09/20/2024 at 20:14, 8 hours 35 minutes ago EQS-Adhoc: GRAMMER AG sells TMD Group in North America
Published on 09/20/2024 at 19:50, 9 hours ago BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Published on 09/20/2024 at 19:47, 9 hours 3 minutes ago EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
Published on 09/20/2024 at 17:40, 11 hours 10 minutes ago Availability of the 2024 Half-Year Financial Report
Published on 09/20/2024 at 17:40, 11 hours 10 minutes ago Mise à disposition du Rapport Financier Semestriel 2024